Ivermectin Could Turn COVID-19 Around. We Need To Find Out If It Works.

Ivermectin Could Turn COVID-19 Around. We Need To Find Out If It Works.

By Mary Beth Pfeiffer

The COVID-19 patient was in critical condition and declining quickly. “Speak to your mom now,” the pulmonologist recalled telling her son, “because after this you may not be able to.” The son pleaded: Was there something else the doctor could do? Anything? That’s when Dr. Jean-Jacques Rajter shared a bit of medical homework he and his wife and partner, Dr. Juliana Cepelowicz Rajter, had done.

There was a well-known drug, but not approved for COVID, he told the son. In Australia, the drug had obliterated the virus in a laboratory culture test. It had cured millions worldwide of parasitic disease; in her native Brazil, Juliana Rajter recalled pediatricians giving it annually to entire families. It was safe. Rajter obtained informed consent – necessary when a patient is given essentially experimental treatment -- and he gave the woman ivermectin. “After 12 hours, she stopped deteriorating,” Jean-Jacques Rajter said. “In 24 hours, she improved. In 48 hours, she didn’t need such a high level of oxygen.” The woman went home in a week.

The Rajters’ ivermectin success was replicated scores of times at four Florida hospitals in the next two months las...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee